603439 Stock Overview
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Guizhou Sanli Pharmaceutical Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.32 |
| 52 Week High | CN¥20.31 |
| 52 Week Low | CN¥10.69 |
| Beta | 0.83 |
| 11 Month Change | -5.53% |
| 3 Month Change | 20.98% |
| 1 Year Change | -32.11% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -62.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 603439 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.9% | -1.5% | -2.1% |
| 1Y | -32.1% | -9.4% | 2.8% |
Return vs Industry: 603439 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 603439 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 603439 volatility | |
|---|---|
| 603439 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603439 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603439's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,282 | Hai Zhang | www.gz-sanli.com |
GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine.
Guizhou Sanli Pharmaceutical Co.,Ltd Fundamentals Summary
| 603439 fundamental statistics | |
|---|---|
| Market cap | CN¥5.33b |
| Earnings (TTM) | CN¥328.87m |
| Revenue (TTM) | CN¥2.11b |
16.2x
P/E Ratio2.5x
P/S RatioIs 603439 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603439 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.11b |
| Cost of Revenue | CN¥626.34m |
| Gross Profit | CN¥1.49b |
| Other Expenses | CN¥1.16b |
| Earnings | CN¥328.87m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.82 |
| Gross Margin | 70.35% |
| Net Profit Margin | 15.57% |
| Debt/Equity Ratio | 31.1% |
How did 603439 perform over the long term?
See historical performance and comparison